NCT03263988View on ClinicalTrials.gov

HD Sense Pilot Study - A Novel Method of Hemodynamic Monitoring

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

October 19, 2017

Primary Completion Date

October 23, 2018

Study Completion Date

December 31, 2019

Conditions
Hemodynamic Instability
Interventions
DEVICE

ConCardiac

All patients receive a piezocapacitative-interlayer-technology hemodynamic measurement by ConCardiac device (SectorCon GmbH, Berlin, Germany).

Trial Locations (1)

10115

Charité - Universitätsmedizin Berlin Campus Charité Mitte, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT03263988 - HD Sense Pilot Study - A Novel Method of Hemodynamic Monitoring | Biotech Hunter | Biotech Hunter